Acumen Pharmaceuticals, Inc. (ABOS)
2.30
+0.06
(+2.68%)
USD |
NASDAQ |
Sep 28, 16:00
2.30
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals Price to Book Value : 2.905 for Sept. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 2.829 |
| September 24, 2026 | 2.822 |
| September 23, 2026 | 2.911 |
| September 22, 2026 | 3.347 |
| September 21, 2026 | 3.271 |
| September 18, 2026 | 3.347 |
| September 17, 2026 | 3.246 |
| September 16, 2026 | 3.296 |
| September 15, 2026 | 3.650 |
| September 14, 2026 | 3.523 |
| September 11, 2026 | 3.688 |
| September 10, 2026 | 3.612 |
| September 09, 2026 | 3.599 |
| September 08, 2026 | 3.991 |
| September 04, 2026 | 4.016 |
| September 03, 2026 | 3.902 |
| September 02, 2026 | 3.915 |
| September 01, 2026 | 3.688 |
| August 31, 2026 | 3.599 |
| August 28, 2026 | 3.688 |
| August 27, 2026 | 3.826 |
| August 26, 2026 | 3.776 |
| August 25, 2026 | 3.915 |
| August 24, 2026 | 3.883 |
| August 21, 2026 | 3.991 |
| Date | Value |
|---|---|
| August 20, 2026 | 4.028 |
| August 19, 2026 | 3.978 |
| August 18, 2026 | 3.460 |
| August 17, 2026 | 3.359 |
| August 14, 2026 | 3.372 |
| August 13, 2026 | 3.220 |
| August 12, 2026 | 3.170 |
| August 11, 2026 | 3.119 |
| August 10, 2026 | 3.069 |
| August 07, 2026 | 3.081 |
| August 06, 2026 | 2.879 |
| August 05, 2026 | 2.829 |
| August 04, 2026 | 2.829 |
| August 03, 2026 | 2.753 |
| July 31, 2026 | 2.715 |
| July 30, 2026 | 2.740 |
| July 29, 2026 | 2.665 |
| July 28, 2026 | 2.879 |
| July 27, 2026 | 2.778 |
| July 24, 2026 | 2.690 |
| July 23, 2026 | 2.740 |
| July 22, 2026 | 2.791 |
| July 21, 2026 | 2.816 |
| July 20, 2026 | 2.791 |
| July 17, 2026 | 2.841 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Biogen, Inc. | 1.792 |
| ACADIA Pharmaceuticals, Inc. | 2.703 |
| Alnylam Pharmaceuticals, Inc. | 25.22 |
| Anika Therapeutics, Inc. | 2.017 |
| Savara, Inc. | 7.256 |
Price to Book Value Related Metrics
| Price | 2.30 |
| Earnings Yield | -70.98% |
| Market Cap | 166.32M |